Synthesis method of acylated isoflavone compound

By hydrolyzing 7,4'-dihydroxyisoflavones with hexamethylenetetramine and organic acid in an inorganic acid solution, an acylated isoflavones compound is solved, and the shortcomings in the synthesis of isoflavones in the prior art are solved. , the synthesis of high-purity and low-cost acylated isoflavone compounds has been achieved, and its antioxidant activity has been significantly improved.

CN118955453APending Publication Date: 2024-11-15ANKANG UNIV
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411004909.4
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-07-25
Publication Date
2024-11-15

AI Technical Summary

Technical Problem

The prior art lacks the use of acylation methods to synthesize isoflavones, resulting in shortcomings in structural and functional modifications.

Method used

Using 7,4'-dihydroxyisoflavone as substrate, the formylation modification is carried out by hydrolysis reaction with hexamethylenetetramine and organic acid in inorganic acid solution to form 8,3'-diformyl- 7,4'-dihydroxyisoflavone, combined with extraction, concentration, drying and separation purification steps, the synthesis of acylated isoflavone compounds is achieved.

Benefits of technology

The high-purity synthesis of acylated isoflavone compounds is achieved, with low cost, good application prospects, and significantly improved their antioxidant activity, achieving the ability to scavenge DPPH radicals comparable to that of ascorbic acid.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118955453A_ABST
    Figure CN118955453A_ABST
Patent Text Reader

Abstract

The invention belongs to the technical field of chemical synthesis, and particularly relates to a synthetic method of an acylated isoflavone compound. The preparation method comprises the following steps: reacting 4, 4 '-dihydroxyisoflavone, a mixture of organic acid and hexamethylenetetramine, adding an inorganic acid solution for hydrolysis reaction, adding a solvent into a reaction product for dilution, and sequentially extracting, concentrating, drying, separating and purifying to obtain the acylated isoflavone compound, the structure of the acylated isoflavone compound is as follows: # imgabs0. The antioxidant activity of the acylated isoflavone compound is measured by adopting a DPPH free radical scavenging method, which indicates that the acylated isoflavone compound has the capacity of scavenging DPPH free radicals, and finds that the acylated isoflavone compound has the antioxidant activity equivalent to that of ascorbic acid.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of chemical synthesis, and in particular relates to a method for synthesizing acylated isoflavone compounds. Background Art

[0002] Isoflavone compounds are a type of 3-phenylchromone compounds, consisting of two benzene rings connected by three carbon atoms in the middle. They are common plant secondary metabolites in the flavonoid class of compounds and are mainly found in plants such as the legume family. Isoflavone compounds have phenolic hydroxyl groups in their structures, so they have multiple biological activities such as anti-inflammatory, antiviral, anti-tumor, antioxidant, and antibacterial. In addition, this type of compound is also widely used in food processing, animal feed additives, water treatment, and functional material preparation, and is an important natural product.

[0003] Acylation is a powerful means to modify the structure and function of substances. It is mainly a process in which different types of acyl groups are introduced into substrate molecules under certain conditions by acylating agents. Through acylation modification, the substrate molecules can be further converted into compounds such as aldehydes (ketones), esters and amides, thereby significantly changing the physicochemical properties and biological activities of the substrates. However, there is currently a lack of methods for synthesizing isoflavone compounds using acylation. Summary of the invention

[0004] The invention discloses a method for synthesizing an acylated isoflavone compound, which solves the current technical problem of lack of isoflavone compound synthesized by acylation. The acylated isoflavone compound (8,3'-diformyl-7,4'-dihydroxy isoflavone) is obtained by using 7,4'-dihydroxy isoflavone as a substrate and performing a synthesis reaction by a formylation modification method. The synthesis conditions of the acylated isoflavone compound are simple and controllable, the synthesis cost is low, the purity is high, and the application prospect is good.

[0005] In order to solve the above technical problems, the present invention provides a method for synthesizing an acylated isoflavone compound. The method comprises: reacting a mixture of 7,4'-dihydroxyisoflavone, an organic acid and hexamethylenetetramine, adding an inorganic acid solution to carry out a hydrolysis reaction, adding a solvent to dilute the reaction product, and then extracting, concentrating and drying, separating and purifying in sequence to obtain the acylated isoflavone compound;

[0006] The structure of the acylated isoflavone compound is shown in formula (1):

[0007]

[0008] In some embodiments, the mixture is reacted at a temperature of 70° C. to 90° C. and a time of 60 min to 120 min.

[0009] In some embodiments, the mixture is reacted at a temperature of 90° C. and a time of 90 min.

[0010] In some embodiments, the molar ratio of the 7,4'-dihydroxyisoflavone, the organic acid and the hexamethylenetetramine is 1:15-25:2-4.

[0011] It should be noted that the molar ratio of the 7,4'-dihydroxyisoflavone, the organic acid and the hexamethylenetetramine can be 1:15:2, 1:15:3, 1:15:4 or 1:20:2, 1:20:3, 1:20:4 or 1:25:2, 1:25:3, 1:25:4 or 1:15:2, 1:20:2, 1:25:2, etc., any one of which is within the molar ratio range, and the embodiment of the present invention does not make any special limitation. The molar ratio of the 7,4'-dihydroxyisoflavone, the organic acid and the hexamethylenetetramine is preferably 1:25:4.

[0012] In some embodiments, the organic acid is any one of formic acid, acetic acid, and trifluoroacetic acid, and preferably trifluoroacetic acid.

[0013] In some embodiments, the inorganic acid is any one of hydrochloric acid and sulfuric acid, preferably hydrochloric acid; the concentration of the inorganic acid is 1 mol / L to 3 mol / L, preferably 3 mol / L.

[0014] In some embodiments, the molar volume ratio of the 7,4'-dihydroxyisoflavone to the inorganic acid is 1 mmol: 1 mL to 3 mL;

[0015] And / or, the molar volume ratio of the 7,4'-dihydroxyisoflavone to the solvent is 1 mmol:15 mL to 30 mL.

[0016] It should be noted that the molar volume ratio of the 7,4'-dihydroxyisoflavone to the inorganic acid can be 1mmol:1mL, 1mmol:2mL, 1mmol:3mL or 1mmol:1.5mL, 1mmol:2.5mL, etc., any one within the molar volume ratio range is acceptable, and the embodiment of the present invention does not make any special limitation. The molar volume ratio of the 7,4'-dihydroxyisoflavone to the inorganic acid is preferably 1mmol:1mL.

[0017] It should be noted that the molar volume ratio of the 7,4'-dihydroxyisoflavone to the solvent can be 1mmol:15mL, 1mmol:20mL, 1mmol:30mL or 1mmol:16mL, 1mmol:24mL, 1mmol:28mL, etc., any one within the molar volume ratio range is acceptable, and the embodiment of the present invention does not make any special limitation. The molar volume ratio of the 7,4'-dihydroxyisoflavone to the solvent is preferably 1mmol:20mL.

[0018] In some embodiments, the solvent is one of distilled water or deionized water.

[0019] In some embodiments, the extraction agent used in the extraction is any one of dichloromethane, chloroform or ethyl acetate. The extraction agent may preferably be ethyl acetate.

[0020] Compared with the prior art, the present invention has the following beneficial effects:

[0021] The acylated isoflavone compound provided by the present invention is obtained by using 7,4'-dihydroxy isoflavone as a substrate, hexamethylenetetramine as a reaction additive, formic acid, acetic acid or trifluoroacetic acid as an organic acid, and hydrochloric acid or sulfuric acid as an inorganic acid, and adopting a formylation modification method for a synthetic reaction. Hexamethylenetetramine forms an iminium ion intermediate under the action of an organic acid, and the iminium ion intermediate undergoes an electrophilic substitution reaction with the ortho position of the substrate 7,4'-dihydroxy isoflavone to form a benzylamine intermediate, and the benzylamine intermediate is further protonated for a second time under the action of an organic acid, and finally undergoes intramolecular oxidation and a hydrolysis process under the action of an inorganic acid to obtain the target final product 8,3'-diformyl-7,4'-dihydroxy isoflavone (acylated isoflavone compound). The present invention realizes the use of a natural product 7,4'-dihydroxy isoflavone as a substrate, and the preparation of a double-formyl-substituted product 8,3'-diformyl-7,4'-dihydroxy isoflavone (acylated isoflavone compound) by a one-pot method. The present invention adopts a DPPH free radical scavenging method to measure the antioxidant activity of 8,3'-diformyl-7,4'-dihydroxyisoflavone, indicating that 8,3'-diformyl-7,4'-dihydroxyisoflavone has the ability to scavenge DPPH free radicals, and finds that 8,3'-diformyl-7,4'-dihydroxyisoflavone has an antioxidant activity equivalent to that of ascorbic acid. The synthesis conditions of the acylated isoflavone compound are simple and controllable, the synthesis cost is low, the purity is high, and the application prospect is good. BRIEF DESCRIPTION OF THE DRAWINGS

[0022] In order to more clearly illustrate the embodiments of the present invention or the technical solutions in the prior art, the drawings required for use in the embodiments or the description of the prior art will be briefly introduced below. Obviously, the drawings described below are only some embodiments of the present invention. For ordinary technicians in this field, other drawings can be obtained based on these drawings without paying creative work.

[0023] Figure 1 The figure is the hydrogen NMR spectrum of the acylated isoflavone compound of the present invention.

[0024] Figure 2 The figure is the carbon-NMR spectrum of the acylated isoflavone compound of the present invention.

[0025] Figure 3 It is a high-resolution mass spectrum of the acylated isoflavone compound of the present invention.

[0026] Figure 4 This is a graph showing the experimental results of the antioxidant activity of the acylated isoflavone compounds of Experimental Example 1 of the present invention. DETAILED DESCRIPTION

[0027] In order to make the purpose, technical scheme and advantages of the present invention more clearly understood, the present invention is further described in detail below in conjunction with the accompanying drawings and examples. It should be understood that the embodiments described herein are only used to explain the present invention and are not intended to limit the present invention. Unless otherwise specified, the raw materials, reagents, etc. used in the following examples can all be obtained from commercial sources.

[0028] In order to enable those skilled in the art to understand the technical solution of the present invention, the technical solution for synthesizing acylated isoflavone compounds of the present invention is described in detail below through specific examples.

[0029] Example 1

[0030] This embodiment provides a method for synthesizing an acylated isoflavone compound, comprising:

[0031] 1 mmol of 7,4'-dihydroxyisoflavone was added to a reaction flask, and then 15 mmol of formic acid was added in an ice-water bath to dissolve the 7,4'-dihydroxyisoflavone, and then 3 mmol of hexamethylenetetramine was added and stirred to dissolve to obtain a mixed solution; the mixed solution was reacted at a temperature of 70°C for 120 minutes, and then heating was stopped, 3 mL of 1 mol / L hydrochloric acid solution was added, and after stirring to room temperature, 15 mL of distilled water was added and stirred for 10 minutes to dilute, to obtain a reaction mixture; the reaction mixture was extracted with dichloromethane to obtain an extract, and after the extract was concentrated and dried, it was separated and purified by silica gel column chromatography to obtain a light yellow powder (product) with a yield of 43%.

[0032] Example 2

[0033] This embodiment provides a method for synthesizing an acylated isoflavone compound, comprising:

[0034] 1 mmol of 7,4'-dihydroxyisoflavone was added to a reaction flask, and then 20 mmol of acetic acid was added under ice-water bath conditions to dissolve the 7,4'-dihydroxyisoflavone, and then 2 mmol of hexamethylenetetramine was added and stirred to dissolve to obtain a mixed solution; the mixed solution was reacted at a temperature of 80°C for 60 minutes, and then heating was stopped, 2 mL of 2 mol / L hydrochloric acid solution was added, and after stirring to room temperature, 30 mL of distilled water was added and stirred for 10 minutes to dilute, to obtain a reaction mixture; the reaction mixture was extracted with chloroform to obtain an extract, and after the extract was concentrated and dried, it was separated and purified by silica gel column chromatography to obtain a light yellow powder (product) with a yield of 40%.

[0035] Example 3

[0036] This embodiment provides a method for synthesizing an acylated isoflavone compound, comprising:

[0037] 1 mmol of 7,4'-dihydroxyisoflavone was added to a reaction flask, and then 25 mmol of trifluoroacetic acid was added in an ice-water bath to dissolve the 7,4'-dihydroxyisoflavone, and then 4 mmol of hexamethylenetetramine was added and stirred to dissolve to obtain a mixed solution; the mixed solution was reacted at a temperature of 90° C. for 90 minutes, and then heating was stopped, 1 mL of 3 mol / L hydrochloric acid solution was added, and after stirring to room temperature, 20 mL of distilled water was added and stirred for 10 minutes to dilute, to obtain a reaction mixture; the reaction mixture was extracted with ethyl acetate to obtain an extract, and after the extract was concentrated and dried, it was separated and purified by silica gel column chromatography to obtain a light yellow powder (product) with a yield of 47%.

[0038] Structure identification:

[0039] The structures of the products prepared in Examples 1-3 were identified respectively, and it was found that the products were all 8,3'-diformyl-7,4'-dihydroxyisoflavone.

[0040] The product prepared in Example 3 is used for illustration. Its H NMR spectrum ( 1 H NMR) Figure 1 As shown, the carbon NMR spectrum ( 13 C NMR) Figure 2 As shown, high resolution mass spectrometry (ESI-HRMS) Figure 3 As shown, the structural characterization data of the product are as follows:

[0041] 1H NMR (400MHz, DMSO): δ12.31(s,1H),10.99(s,1H),10.51(s,1H),10.33(s,1H),8.59(s,1H),8.27( d,J=9.0Hz,1H),7.94(s,1H),7.75(d,J=8.6Hz,1H),7.15(d,J=9.0Hz,1H),7.10(d,J=8.6Hz,1H); 13 C NMR (100MHz, DMSO): δ191.43,190.17,174.31,166.51,161.15,157.27,153.94,137.24,13 3.95,129.74,123.89,122.99,122.56,117.70,116.85,116.53,110.37;ESI-HRMS(m / z),C 17 H 10 O6(M)310.0477,Found 309.0408[(MH) - ].

[0042] According to the spectrum and NMR data, it can be confirmed that the obtained light yellow powder is 8,3'-diformyl-7,4'-dihydroxyisoflavone, and its structure is shown in the following formula:

[0043]

[0044] Experimental Example 1

[0045] This experimental example provides an antioxidant activity experiment of an acylated isoflavone compound.

[0046] The antioxidant activity of the product 8,3'-diformyl-7,4'-dihydroxyisoflavone prepared above was determined by DPPH free radical scavenging method, and compared with the antioxidant activity of the reaction substrate 7,4'-dihydroxyisoflavone and ascorbic acid (Vc). The test method is as follows:

[0047] The samples were prepared into different mass concentrations (8 μg.mL -1 , 16μg.mL -1 , 32μg.mL -1 , 64μg.mL -1 , 128μg.mL -1 , 256μg.mL -1 , 512μg.mL -1 ) of the sample solution to be tested, take 100 μL of the sample solution to be tested, and mix with an equal volume of DPPH (0.2 mmol.L -1) solution was fully mixed, reacted in the dark at room temperature for 30 minutes, and the absorbance value (A1) was measured at a wavelength of 520 nm. The absorbance value (A0) was measured by replacing the sample with deionized water, and the absorbance value (A2) was measured by replacing the DPPH solution with deionized water. The scavenging ability of the DPPH free radical of the measured sample was calculated according to formula (I), so as to characterize the antioxidant activity of the sample according to the degree of free radical scavenging effect;

[0048] DPPH free radical scavenging rate = (1-(A1-A2) / A0) × 100% (-).

[0049] 7,4'-dihydroxyisoflavone, 8,3'-diformyl-7,4'-dihydroxyisoflavone and positive control Vc were used as samples to carry out antioxidant activity determination experiments. The free radical scavenging activities of different samples were measured as follows: Figure 4 shown.

[0050] Depend on Figure 4 It can be seen that there is a phenolic hydroxyl structure in the structure of 7,4'-dihydroxyisoflavone, which has a certain DPPH free radical scavenging effect. Compared with 7,4'-dihydroxyisoflavone, the ability of 8,3'-diformyl-7,4'-dihydroxyisoflavone to scavenge DPPH free radicals is significantly improved. The 8,3'-diformyl-7,4'-dihydroxyisoflavone prepared after modification not only retains the original active phenolic hydroxyl structure, but also introduces a formyl group. The presence of the formyl group activates the adjacent phenolic hydroxyl hydrogen, thereby showing an antioxidant activity equivalent to that of the positive control Vc.

[0051] Although the preferred embodiments of the present invention have been described, those skilled in the art may make other changes and modifications to these embodiments once they have learned the basic creative concept. Therefore, the appended claims are intended to be interpreted as including the preferred embodiments and all changes and modifications that fall within the scope of the present invention.

[0052] Obviously, those skilled in the art can make various changes and modifications to the present invention without departing from the spirit and scope of the present invention. Thus, if these modifications and variations of the present invention fall within the scope of the claims of the present invention and their equivalents, the present invention is also intended to include these modifications and variations.

Claims

1. A method for synthesizing an acylated isoflavone compound, characterized in that: The steps include: After reacting a mixture of 7,4'-dihydroxyisoflavone, an organic acid and hexamethylenetetramine, an inorganic acid solution is added to carry out a hydrolysis reaction, and after adding a solvent to dilute the reaction product, extraction, concentration, drying, separation and purification are carried out in sequence to obtain the acylated isoflavone compound; The structure of the acylated isoflavone compound is shown in formula (1):

2. The method for synthesizing the acylated isoflavone compound according to claim 1, characterized in that: The mixture is reacted at a temperature of 70° C. to 90° C. and for a time of 60 min to 120 min.

3. The method for synthesizing the acylated isoflavone compound according to claim 2, characterized in that: The mixture was reacted at a temperature of 90° C. and a reaction time of 90 min.

4. The method for synthesizing the acylated isoflavone compound according to claim 1, characterized in that: The molar ratio of the 7,4'-dihydroxyisoflavone, the organic acid and the hexamethylenetetramine is 1:15-25:2-4.

5. The method for synthesizing the acylated isoflavone compound according to claim 4, characterized in that: The molar ratio of the 7,4'-dihydroxyisoflavone, the organic acid and the hexamethylenetetramine is 1:25:

4.

6. The method for synthesizing acylated isoflavone compounds according to claim 1, characterized in that: The organic acid is any one of formic acid, acetic acid and trifluoroacetic acid.

7. The method for synthesizing the acylated isoflavone compound according to claim 6, characterized in that: The organic acid is trifluoroacetic acid.

8. The method for synthesizing acylated isoflavone compounds according to claim 1, characterized in that: The inorganic acid is any one of hydrochloric acid and sulfuric acid; The concentration of the inorganic acid is 1 mol / L to 3 mol / L.

9. The method for synthesizing acylated isoflavone compounds according to claim 1, characterized in that: The molar volume ratio of the 7,4'-dihydroxyisoflavone to the inorganic acid is 1 mmol: 1 mL to 3 mL; And / or, the molar volume ratio of the 7,4'-dihydroxyisoflavone to the solvent is 1 mmol:15 mL to 30 mL.

10. The method for synthesizing acylated isoflavone compounds according to claim 9, characterized in that: The solvent is any one of distilled water or deionized water.